SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro DiagnosticsInfectious Disease

PUBLISHER: Grand View Research | PRODUCT CODE: 2152346

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2152346

Rapid STI Testing Market Size, Share & Trends Analysis Report By Technology (Molecular Diagnostics/NAAT, Rapid Immunoassays), By Infection Type, By Test Type, By Sample Type, By End Use, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Rapid STI Testing Market Summary

The global rapid STI testing market size was valued at USD 1.5 billion in 2025 and is projected to grow from USD 1.6 billion in 2026 to USD 2.8 billion by 2033, at a CAGR of 8.7% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 41.1% in 2025. Market growth is primarily driven by the rising global burden of sexually transmitted infections, which is increasing demand for rapid, accessible, and timely diagnostic testing

Global Rapid STI Testing Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Single-target Tests has segmented the Rapid STI testing market report on the basis of technology, infection type, test type, sample type, end use and region.

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Molecular Diagnostics / NAAT
  • Rapid Immunoassays
  • Others
  • Infection Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Chlamydia
  • Gonorrhea
  • SYPHILIS
  • TRICHOMONIASIS
  • Mycoplasma genitalium
  • Multiple STI Targets
  • Other STI Targets
  • Test Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Single-target Tests
  • Multiplex / Combination Tests
  • Sample Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Urine
  • Swab Specimens
  • Whole Blood / Serum / Plasma
  • Other Specimens
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics
  • Diagnostic Laboratories & Near-Point-of-Care Facilities
  • Public Health & Community Testing Settings
  • Home / Self-testing
  • Other End Uses
  • Rapid STI Testing Market Regional Outlook (Revenue, USD Million; 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-4-68041-047-5

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Technology Segment
    • 1.2.2. Infection Type Segment
    • 1.2.3. Test Type Segment
    • 1.2.4. Sample Type Segment
    • 1.2.5. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Global Rapid STI Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Technological Innovation in Rapid STI Diagnostic Technologies and Point-of-Care Testing
      • 3.2.1.2. Growing Global Burden of Sexually Transmitted Infections
      • 3.2.1.3. Increasing Adoption of Decentralized and Point-of-Care STI Testing
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Regulatory, Performance, and Cost Barriers Limiting Rapid STI Testing Adoption
      • 3.2.2.2. Risk of False-Positive and False-Negative Results
    • 3.2.3. Market opportunity analysis
  • 3.3. Global Rapid STI Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Global Rapid STI Testing Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Rapid STI Testing Market Technology Movement Analysis
  • 4.3. Global Rapid STI Testing Market Size & Trend Analysis by Technology, 2021 to 2033 (USD Million)
  • 4.4. Molecular Diagnostics / NAAT
    • 4.4.1. Molecular Diagnostics / NAAT market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Rapid Immunoassays
    • 4.5.1. Rapid Immunoassays market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. Others
    • 4.6.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Global Rapid STI Testing Market: Infection Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Rapid STI Testing Market Infection Type Movement Analysis
  • 5.3. Global Rapid STI Testing Market Size & Trend Analysis, by Infection Type, 2021 to 2033 (USD Million)
  • 5.4. Chlamydia
    • 5.4.1. Chlamydia market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Gonorrhea
    • 5.5.1. Gonorrhea market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Syphilis
    • 5.6.1. Syphilis market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7. Trichomoniasis
    • 5.7.1. Trichomoniasis market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.8. Mycoplasma genitalium
    • 5.8.1. Mycoplasma genitalium market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.9. Multiple STI Targets
    • 5.9.1. Multiple STI Targets market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.10. Other
    • 5.10.1. Other market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Global Rapid STI Testing Market: Test Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Rapid STI Testing Market Test Type Movement Analysis
    • 6.2.1. Global Rapid STI Testing Market Size & Trend Analysis, by Test Type, 2021 to 2033 (USD Million)
  • 6.3. Single-target Tests
    • 6.3.1. Single-target Tests market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.4. Multiplex / Combination Tests
    • 6.4.1. Multiplex / Combination Tests market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Global Rapid STI Testing Market: Sample Type Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Rapid STI Testing Market Sample Type Movement Analysis
    • 7.2.1. Global Rapid STI Testing Market Size & Trend Analysis, by Sample Type, 2021 to 2033 (USD Million)
  • 7.3. Urine
    • 7.3.1. Urine market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4. Swab Specimens
    • 7.4.1. Swab Specimens market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Whole Blood / Serum / Plasma
    • 7.5.1. Whole Blood / Serum / Plasma market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Other Specimens
    • 7.6.1. Other Specimens market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Global Rapid STI Testing Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global Rapid STI Testing Market End Use Movement Analysis
    • 8.2.1. Global Rapid STI Testing Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 8.3. Hospitals & Clinics
    • 8.3.1. Hospitals & Clinics market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.4. Diagnostic Laboratories & Near-Point-of-Care Facilities
    • 8.4.1. Diagnostic Laboratories & Near-Point-of-Care Facilities market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5. Public Health & Community Testing Settings
    • 8.5.1. Public Health & Community Testing Settings market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6. Home / Self-testing
    • 8.6.1. Home / Self-testing market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7. Other End Uses
    • 8.7.1. Other End Uses market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Rapid STI Testing Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Dashboard
  • 9.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 9.3. North America
    • 9.3.1. U.S.
      • 9.3.1.1. Key country dynamics
      • 9.3.1.2. Regulatory framework/ reimbursement structure
      • 9.3.1.3. Competitive scenario
      • 9.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.3.2. Canada
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Regulatory framework/ reimbursement structure
      • 9.3.2.3. Competitive scenario
      • 9.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.3.3. Mexico
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Regulatory framework/ reimbursement structure
      • 9.3.3.3. Competitive scenario
      • 9.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.4. Europe
    • 9.4.1. UK
      • 9.4.1.1. Key country dynamics
      • 9.4.1.2. Regulatory framework/ reimbursement structure
      • 9.4.1.3. Competitive scenario
      • 9.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.4.2. Germany
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Regulatory framework/ reimbursement structure
      • 9.4.2.3. Competitive scenario
      • 9.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.4.3. France
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Regulatory framework/ reimbursement structure
      • 9.4.3.3. Competitive scenario
      • 9.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.4.4. Italy
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Regulatory framework/ reimbursement structure
      • 9.4.4.3. Competitive scenario
      • 9.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.4.5. Spain
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Regulatory framework/ reimbursement structure
      • 9.4.5.3. Competitive scenario
      • 9.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.4.6. Norway
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Regulatory framework/ reimbursement structure
      • 9.4.6.3. Competitive scenario
      • 9.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.4.7. Sweden
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. Regulatory framework/ reimbursement structure
      • 9.4.7.3. Competitive scenario
      • 9.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.4.8. Denmark
      • 9.4.8.1. Key country dynamics
      • 9.4.8.2. Regulatory framework/ reimbursement structure
      • 9.4.8.3. Competitive scenario
      • 9.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Japan
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework/ reimbursement structure
      • 9.5.1.3. Competitive scenario
      • 9.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.5.2. China
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework/ reimbursement structure
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.5.3. India
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework/ reimbursement structure
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.5.4. Australia
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Regulatory framework/ reimbursement structure
      • 9.5.4.3. Competitive scenario
      • 9.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.5.5. South Korea
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Regulatory framework/ reimbursement structure
      • 9.5.5.3. Competitive scenario
      • 9.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.5.6. Thailand
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Regulatory framework/ reimbursement structure
      • 9.5.6.3. Competitive scenario
      • 9.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Brazil
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework/ reimbursement structure
      • 9.6.1.3. Competitive scenario
      • 9.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.6.2. Argentina
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework/ reimbursement structure
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.7. MEA
    • 9.7.1. South Africa
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework/ reimbursement structure
      • 9.7.1.3. Competitive scenario
      • 9.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.7.2. Saudi Arabia
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework/ reimbursement structure
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.7.3. UAE
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework/ reimbursement structure
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.7.4. Kuwait
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Regulatory framework/ reimbursement structure
      • 9.7.4.3. Competitive scenario
      • 9.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company/Competition Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Share Analysis, 2025
  • 10.4. List of Key Certification Providers/Scheme Owners
  • 10.5. Company Profiles/Listing
    • 10.5.1. Danaher Corporation
      • 10.5.1.1. Company overview
      • 10.5.1.2. Financial performance
      • 10.5.1.3. Technology benchmarking
      • 10.5.1.4. Strategic initiatives
    • 10.5.2. F. Hoffmann-La Roche Ltd
      • 10.5.2.1. Company overview
      • 10.5.2.2. Financial performance
      • 10.5.2.3. Product benchmarking
      • 10.5.2.4. Strategic initiatives
    • 10.5.3. Abbott
      • 10.5.3.1. Company overview
      • 10.5.3.2. Financial performance
      • 10.5.3.3. Product benchmarking
      • 10.5.3.4. Strategic initiatives
    • 10.5.4. Visby Medical, Inc.
      • 10.5.4.1. Company overview
      • 10.5.4.2. Financial performance
      • 10.5.4.3. Product benchmarking
      • 10.5.4.4. Strategic initiatives
    • 10.5.5. SD Biosensor, INC.
      • 10.5.5.1. Company overview
      • 10.5.5.2. Financial performance
      • 10.5.5.3. Product benchmarking
      • 10.5.5.4. Strategic initiatives
    • 10.5.6. Premier Medical
      • 10.5.6.1. Company overview
      • 10.5.6.2. Financial performance
      • 10.5.6.3. Product benchmarking
      • 10.5.6.4. Strategic initiatives
    • 10.5.7. bioLytical Laboratories Inc.
      • 10.5.7.1. Company overview
      • 10.5.7.2. Financial performance
      • 10.5.7.3. Product benchmarking
      • 10.5.7.4. Strategic initiatives
    • 10.5.8. Biosynex SA
      • 10.5.8.1. Company overview
      • 10.5.8.2. Financial performance
      • 10.5.8.3. Product benchmarking
      • 10.5.8.4. Strategic initiatives
    • 10.5.9. Trinity Biotech plc
      • 10.5.9.1. Company overview
      • 10.5.9.2. Financial performance
      • 10.5.9.3. Product benchmarking
      • 10.5.9.4. Strategic initiatives
    • 10.5.10. Guangzhou Wondfo Biotech Co., Ltd
      • 10.5.10.1. Company overview
      • 10.5.10.2. Financial performance
      • 10.5.10.3. Product benchmarking
      • 10.5.10.4. Strategic initiatives
    • 10.5.11. InTec Products, Inc.
      • 10.5.11.1. Company overview
      • 10.5.11.2. Financial performance
      • 10.5.11.3. Product benchmarking
      • 10.5.11.4. Strategic initiatives
    • 10.5.12. Access Bio, Inc.
      • 10.5.12.1. Company overview
      • 10.5.12.2. Financial performance
      • 10.5.12.3. Product benchmarking
      • 10.5.12.4. Strategic initiatives
Show more
Product Code: GVR-4-68041-047-5

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 4 Global Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 5 Global Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 6 Global Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 7 Global Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)
  • Table 8 North America Rapid STI Testing Market, by region, 2021- 2033 (USD Million)
  • Table 9 North America Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 10 North America Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 11 North America Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 12 North America Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 13 North America Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)
  • Table 14 U.S. Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 15 U.S. Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 16 U.S. Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 17 U.S. Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 18 U.S. Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)
  • Table 19 Canada Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 20 Canada Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 21 Canada Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 22 Canada Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 23 Canada Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)
  • Table 24 Mexico Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 25 Mexico Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 26 Mexico Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 27 Mexico Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 28 Mexico Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)
  • Table 29 Europe Rapid STI Testing Market, by region, 2021- 2033 (USD Million)
  • Table 30 Europe Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 31 Europe Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 32 Europe Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 33 Europe Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 34 Europe Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)
  • Table 35 UK Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 36 UK Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 37 UK Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 38 UK Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 39 UK Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)
  • Table 40 Germany Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 41 Germany Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 42 Germany Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 43 Germany Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 44 Germany Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)
  • Table 45 France Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 46 France Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 47 France Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 48 France Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 49 France Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)
  • Table 50 Italy Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 51 Italy Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 52 Italy Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 53 Italy Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 54 Italy Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)
  • Table 55 Spain Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 56 Spain Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 57 Spain Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 58 Spain Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 59 Spain Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)
  • Table 60 Denmark Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 61 Denmark Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 62 Denmark Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 63 Denmark Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 64 Denmark Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)
  • Table 65 Sweden Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 66 Sweden Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 67 Sweden Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 68 Sweden Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 69 Sweden Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)
  • Table 70 Norway Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 71 Norway Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 72 Norway Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 73 Norway Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 74 Norway Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)
  • Table 75 Asia Pacific Rapid STI Testing Market, by region, 2021- 2033 (USD Million)
  • Table 76 Asia Pacific Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 77 Asia Pacific Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 78 Asia Pacific Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 79 Asia Pacific Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 80 Asia Pacific Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)
  • Table 81 Japan Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 82 Japan Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 83 Japan Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 84 Japan Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 85 Japan Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)
  • Table 86 China Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 87 China Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 88 China Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 89 China Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 90 China Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)
  • Table 91 India Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 92 India Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 93 India Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 94 India Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 95 India Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)
  • Table 96 Australia Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 97 Australia Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 98 Australia Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 99 Australia Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 100 Australia Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)
  • Table 101 South Korea Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 102 South Korea Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 103 South Korea Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 104 South Korea Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 105 South Korea Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)
  • Table 106 Thailand Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 107 Thailand Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 108 Thailand Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 109 Thailand Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 110 Thailand Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)
  • Table 111 Latin America Rapid STI Testing Market, by region, 2021- 2033 (USD Million)
  • Table 112 Latin America Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 113 Latin America Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 114 Latin America Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 115 Latin America Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 116 Latin America Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)
  • Table 117 Brazil Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 118 Brazil Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 119 Brazil Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 120 Brazil Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 121 Brazil Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)
  • Table 122 Argentina Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 123 Argentina Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 124 Argentina Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 125 Argentina Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 126 Argentina Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)
  • Table 127 MEA Rapid STI Testing Market, by region, 2021- 2033 (USD Million)
  • Table 128 MEA Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 129 MEA Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 130 MEA Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 131 MEA Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 132 MEA Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)
  • Table 133 South Africa Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 134 South Africa Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 135 South Africa Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 136 South Africa Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 137 South Africa Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)
  • Table 138 Saudi Arabia Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 139 Saudi Arabia Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 140 Saudi Arabia Rapid STI Testing Market, by Test Type, 2021 - 20332021 - 20332021 - 2033 (USD Million)
  • Table 141 Saudi Arabia Rapid STI Testing Market, by Sample Type, 2021 - 20332021 - 20332021 - 2033 (USD Million)
  • Table 142 Saudi Arabia Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)
  • Table 143 UAE Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 144 UAE Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 145 UAE Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 146 UAE Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 147 Kuwait Rapid STI Testing Market, by Technology, 2021- 2033 (USD Million)
  • Table 148 Kuwait Rapid STI Testing Market, by Infection Type, 2021- 2033 (USD Million)
  • Table 149 Kuwait Rapid STI Testing Market, by Test Type, 2021 - 2033 (USD Million)
  • Table 150 Kuwait Rapid STI Testing Market, by Sample Type, 2021 - 2033 (USD Million)
  • Table 151 Kuwait Rapid STI Testing Market, by End Use, 2021- 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Rapid STI Testing Market: Market outlook
  • Fig. 9 Rapid STI Testing Market: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Rapid STI testing market driver impact
  • Fig. 15 Rapid STI testing market restraint impact
  • Fig. 16 Rapid STI testing market strategic initiatives analysis
  • Fig. 17 Rapid STI testing market: Technology movement analysis
  • Fig. 18 Rapid STI testing market: Technology outlook and key takeaways
  • Fig. 19 Rapid Immunoassays & systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Molecular Diagnostics / NAAT market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Rapid STI testing market: Infection Type movement analysis
  • Fig. 23 Rapid STI testing market: Infection Type outlook and key takeaways
  • Fig. 24 Chlamydia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Gonorrhea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Syphilis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Trichomoniasis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Mycoplasma genitalium market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Multiple STI Targets market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Other market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Rapid STI testing market: Test Type movement analysis
  • Fig. 32 Rapid STI testing market: Test Type outlook and key takeaways
  • Fig. 33 Single-target Tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Multiplex / Combination Tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Rapid STI testing market: Sample Type movement analysis
  • Fig. 36 Rapid STI testing market: Sample Type outlook and key takeaways
  • Fig. 37 Urine market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Swab Specimens market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Whole Blood / Serum / Plasma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Other Specimens market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Rapid STI testing market: End Use movement analysis
  • Fig. 42 Rapid STI testing market: End Use outlook and key takeaways
  • Fig. 43 Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Hospitals & diagnostic labs market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Pharma & biotech companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Home / Self-testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Other End Uses market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Global Rapid STI testing market: Regional movement analysis
  • Fig. 49 Global Rapid STI testing market: Regional outlook and key takeaways
  • Fig. 50 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Middle East and Africa. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!